How Pharmaceuticals Impact the Environment: EMA Revises Guideline

The revision of the European Medicines Agency’s (EMA) guideline on environmental risk assessment (ERA) introduces a decision tree clarifying when ERA studies are required and provides more detailed technical guidance to help increase the consistency of the assessments.